Bvf Inc Vigil Neuroscience, Inc. Transaction History
Bvf Inc
- $3.34 Billion
- Q1 2024
A detailed history of Bvf Inc transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Bvf Inc holds 1,813,633 shares of VIGL stock, worth $7.25 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
1,813,633
Previous 1,813,633
-0.0%
Holding current value
$7.25 Million
Previous $6.13 Million
0.88%
% of portfolio
0.19%
Previous 0.16%
Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
54Shares Held
26.7MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$23.3 Million2.49% of portfolio
-
Northpond Ventures, LLC4.21MShares$16.9 Million40.32% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.17MShares$8.66 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N41.81MShares$7.24 Million0.33% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.73MShares$6.92 Million0.92% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $113M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...